Scandinavian Candesartan Acute Stroke Trial (SCAST)
- Prosjektnummer
- 2007061
- Ansvarlig person
- Eivind Berge
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Stroke
- Forskningsaktivitet
- 6. Treatment Evaluation
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Lancet 2011 Feb;377(9767):741-50.
PMID: 21316752
Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).
Int J Stroke 2010 Oct;5(5):423-7.
PMID: 20854630
Should high blood pressure be lowered in the acute stroke?
J Hypertens 2011 Aug;29(8):1478-9.
PMID: 21750435
Scandinavian Candesartan Acute Stroke Trial (abstract).
Stroke 2010;41(4):e254-e393.
Scandinavian Candesartan Acute Stroke Trial (abstract)
Cerebrovasc Dis 2010;29 (Suppl.2):1-341.
Scandinavian Candesartan Acute Stroke Trial.
Hjerteforum 2010;23(3):96.
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-bli
Stroke 2011;42:e42-e110.
Effects of candesartan on vascular events and functional outcome in patients with acute stroke and high blood pressure.
Cerebrovasc Dis 2011;31(Suppl.2):1-341.
Relation between change in systolic blood pressure and risk of stroke progression, stroke recurrence and poor functional outcome
Cerebrovasc Dis 2011; 31(Suppl.2):1-341.
Effects of blood pressure lowering treatment in patients with acute ischemic stroke and carotid artery stenosis in the Scandinav
Cerebrovasc Dis 2011;31(Suppl.2):1-341.
Blood pressure treatment with candesartan in acute stroke: the Scandinavian Candesartan Acute Stroke Trial (abstract).
J Hypertens 2011;29(e-Suppl. A):e33.
Efficiency gains resulting from the ordinal analysis of a functional outcome scale: a case study of a major phase III stroke tri
UK MRC Trials methodology conference, Bristol, 2011.
Scandinavian Candesartan Acute Stroke Trial (Abstract)
Stroke 2009;40(4):e105-276
Berge E, et al. Scandinavian Candesartan Acute Stroke Trial (Abstract)
Cerebrovasc Dis 2009;27(suppl 6):1-256
Scandinavian Candesartan Acute Stroke Trial: Background and Methods
Submitted to International Journal of Stroke
Scandinavian Candesartan Acute Stroke Trial (SCAST) (NCT00120003; ISRCTN13643354)
http://www.thelancet.com/journals/lancet/misc/protocol/05PRT-14
Major ongoing trials: Scandinavian Candesartan Acute Stroke Trial
Stroke 2008;39(10): e159-60
Methods and design of the Scandinavian Candesartan Acute Stroke Trial (SCAST)
International Journal of Stroke 2009 (submitted)
Scandinavian Candesartan Acute Stroke Trial (abstract)
Stroke 2008;39(2)
Scandinavian Candesartan Acute Stroke Trial (abstract)
Cerebrovasc Dis 2008;25(S2):1
Scandinavian Candesartan Acute Stroke Trial (abstract)
International Journal of Stroke 2008;3(1):138-9
Blood pressure lowering treatment in acute stroke (innleveres februar 2012)
- Disputert:
- desember 2011
- Hovedveileder:
- Eivind Berge
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport